University of Queensland   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Brisbane Australia (1909)

Organization Overview

First Clinical Trial
1998
NCT00097669
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

ANZIC-Research Centre; Australian Defence Force, University of Queensland, | Brisbane Public Hospital | Brisbane South Medical Centre | Children's Health Queensland | Dermatology Department, Brisbane Public Hospital | Greenslopes Private Hospital | Isopogen | Lady Cilento Children's Hospital, Brisbane | Nambour General Hospital, Queensland | QIMR Berghofer Medical Research Institute | Queensland Centre for Gynaecological Cancer | Queensland Children's Medical Research Institute | Queensland Children's Medical Research Unit, Herston, AUS | Queensland Institute for Medical Research | Queensland Institute of Medical Research | Redcliffe Hospital, Brisbane, Qld., Australia | Royal Brisbane and Women's Hospital | Royal Brisbane and Womens Hospital | Royal Brisbane and Womens Hospital, Brisbane, Australia | Royal Brisbane & Women's Hospital, QLD, Australia | Royal Brisbane & Women's Hpsoital | The Prince Charles Hospital | The Prince Charles Hospital, Centre for Biodiscovery and Molecular Development of Therapeutics | The Univeristy of Queensland | The University of Queensland | The University of Queensland Centre for Clinical Research | Univeristy of Queensland | University of Queeensland, University of South Australia | University of Queensland, Queensland, Australia | University of Queensland, Queensland Health | University of Queensland & The Prince Charles Hospital | UQCCR